Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study

A Zullo, V De Francesco, G Scaccianoce, Cesare Hassan, A Panarese, D Piglionica, C Panella, S Morini, E. Ierardi

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Helicobacter pylori eradication rate with standard triple therapies is decreasing. Recently, lactoferrin administration has been shown to significantly increase the cure rate of 7-day rabeprazole, clarithromycin and tinidazole triple therapy. We assessed whether lactoferrin also increases the eradication rate of 7-day esomeprazole, clarithromycin and amoxycillin triple therapy as first-line treatment.
Original languageEnglish
Pages (from-to)496-500
Number of pages5
JournalDigestive and Liver Disease
Volume37
DOIs
Publication statusPublished - 2005
Externally publishedYes

Keywords

  • Amoxicillin
  • Anti-Bacterial Agents
  • Clarithromycin
  • Drug Therapy, Combination
  • Dyspepsia
  • Helicobacter Infections
  • Helicobacter pylori
  • Humans
  • Lactoferrin
  • Prospective Studies

Fingerprint

Dive into the research topics of 'Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study'. Together they form a unique fingerprint.

Cite this